thank stand welcome perkinelmer third quarter earn conference call operator instruction would like hand conference speaker today vice president investor relation please ahead vice president investor relation good afternoon everyone welcome perkinelmer third quarter earn conference call call today president chief executive officer senior vice president chief financial officer founder chief executive receive copy earn press release slide presentation find copy investor section website perkinelmer please note call webcast archive website begin like remind everyone safe harbor statement outline earn press release issue earlier afternoon also file statement comment make call forward look statement include necessarily limit financial projection statement company plan objective expectation intention matter involve certain risk uncertainty company actual result differ significantly project suggest forward look statement variety factor discuss detail file forward look statement make today represent view today disclaim obligation update forward look statement future even estimate change rely today forward look statement represent view date today call refer certain financial measure reconciliation financial measure plan call directly comparable measure available attachment earn press release extent financial measure call reconcile attachment promptly turn president chief executive officer president chief executive good afternoon everyone reflect third quarter confidently effort investment business performance together truly reflect essence impact perkinelmer concept introduce analyst meet back operational improvement recent acquisition life science diagnostics investment food apply market accelerate innovation across board ramp focus culture employee engagement technological innovation collectively bear fruit still significantly come think strong financial result additional color share today illustrate immense incremental value deliver stakeholder position future stay idea moment ongoing portfolio transformation higher growth market continue third quarter close previously announce acquisition biotech system also announce able fairly quickly close largest acquisition date three month ahead schedule touch great recent addition bite thrill initial teamwork already occur business rest perkinelmer collaboration already underway expect expand turbocharged come companywide innovation summit host couple week proud employee around world continue execute third quarter despite face exist challenge even start come across provide detail bite like highlight organic growth generate quarter solidly ahead guidance revenue come close twice expectation test remain similar level experience second quarter supply ready meet incremental demand lead adjust earn share quarter guidance despite ongoing strong investment back business overall continue strong demand trend across business double digit growth major region face headwind feel proactively respond execute customer successfully past year numerous pressure across business global economy please strong performance third quarter excite recent acquisition want spend little time today share insight newer addition opportunity greater detail investor point first like touch close back march mention founder join today call many know stand alone publicly trade company currently number player latent test market globally think core capability broader regulatory distribution service offer business position gain share year ahead term happen since join perkinelmer family earlier year extremely please share pace exceed revenue target year make great progress roll automation workflow around world anticipate approval workflow next year think might helpful share company already collaborate within first month roof hope give feel synergy potential believe exist help integration transformation office last year perkinelmer already leverage capability number integrate liquid medium throughput automation workflow currently seek receive regulatory approval around world utilize cell count instrument high throughput automation workflow addition also already start leverage perkinelmer exist field service force assist installation automation offer begin transition developer manufacturer diagnostic offer customer fully automate workflow test still early many plan process play longer term example initial progress quite excite like turn share think business since become part perkinelmer family maybe perspective business come year chief executive officer thank strategy advance attractive grow latent test market base number pillar firstly expand commercial presence maximize penetration exist country secondly dramatically improve workflow automate assay bring automate workflow major jurisdiction worldwide variety throughput suit customer different size thirdly improve economics customer reduce good customer advantage also capture value product service ecosystem create automation part wider perkinelmer family help execute better three area example already leverage presence field force access country south leverage presence relationship accelerate automation journey already mention adopt perkinelmer suite automation core perkinelmer form utilize technology acquire company also able capture value automation pathway perkinelmer business global supply chain capability sell automation consumables automation service contract thing equip also explore number additional reduction opportunity source material currently purchase third party particular number antibody immunological reagent look incorporate immunology base technology time able streamline structure clearly longer support public company infrastructure generally able reduce spend leverage perkinelmer capability area together even month since become part perkinelmer family intensify revenue growth improve profitability bottom line also grow success deploy cell technology test service revenue continue grow support phase phase licensure study support vaccine deployment decision umbrella vaccine task force side also grow mature demand important role cell become widely recognize critical mean assess vaccine efficacy particularly immunosuppressed high risk population support close peer review publication technology cell test come mainstream several country believe test last probably beyond learn live endemic mutate global virus also opportunity grow immunology test service support vaccine pharma client broadly outside clearly respect capability cell test part perkinelmer distinct advantage firstly leverage infrastructure perkinelmer global network specialty clinical laboratory establish wider worldwide coverage something grow importance vaccine pharma client want trial world secondly partner world lead portfolio immunology research reagent give expertise rapidly expand service offer beyond core technology like hand back president chief executive look forward traction make come quarter also want share recent acquisition system close early bite analyst meet announcement acquire want make sure shareholder know excite become part perkinelmer believe bring overall company addition great example expect plus equal least three hopefully first tell bite company developer manufacturer medium throughput chemiluminescence analyzer assay previously publicly trade evolution assay menu last several year significantly enhance house chemiluminescence assay development expertise expertise provide even resource support development launch high throughput random access system expect introduce next year furthermore exist throughput chemiluminescence analyzer current base business upon launch platform able offer spectrum chemiluminescence system assay customer also first month since acquisition close start leverage commercial distribution strength example recent meet perkinelmer diagnostics jointly exhibit meet customer person first time course addition close largest deal company history keep busy least happy able close deal several month year colleague involve ready head next year part perkinelmer financial performance continue remain extremely strong miss beat part transition testament strong leadership throughout terrific business seamlessly customer also work tirelessly ensure successful transition perkinelmer family however even excite interaction collaboration begin take place broader perkinelmer organization briefly mention earlier especially look forward upcoming companywide innovation summit plan later year campus event bring together innovation commercial operational leader expert across company several collaborate know another wait impactful idea connection come event relate innovation early receive emergency authorization respiratory assay provide detection single assay others expect play larger role test come winter month northern hemisphere additionally business recently receive emergency authorization quantitative serology assay target protein assay exist strong portfolio serology antigen assay ongoing fight pandemic corporate responsibility standpoint world still evolve place colleague effort recent companywide global impact hold last month great different group initiative take place lead colleague around world recall outline initial relate target analyst meet delight effort already underway work toward achieve instance recently complete companywide employee engagement survey ensure perkinelmer continue great place work everyone proud part initial result look positive front engagement diversity inclusion health perspective quite sure always room improvement additionally recently release corporate social responsibility report begin report quickly consider lead industry standard platform perkinelmer adhere framework build historical report carbon disclosure project align task force climate relate financial disclosure confident good plan initial target place happy company formally rally around effort close always seem various external pressure must face current semiconductor shortage logistics bottleneck potential global reform proud continue proactively navigate challenge agility innovation unique dedicate focus customer strong global teamwork corporate character allow successfully mitigate impact various challenge provide opportunity continue achieve even exceed plan like third quarter year always busy time fill commercial activity strategic operational plan professional personal commitment expect year confident like turn call provide detail perspective third quarter result color relate guidance fourth quarter senior vice president chief financial good even everyone turn financial result want remind everyone third quarter earn call presentation post investor section website financial information mention quite busy quarter company believe perform extremely continue make great traction execute transformation business organic operational perspective also inorganically touch bite revenue performance exceed expectation double digit growth discovery analytical solution diagnostics segment additionally recent addition perkinelmer family remain track head year third quarter adjust revenue grow compare last year almost billion include foreign exchange tailwind contribution recent acquisition organic revenue grow percentage point better guidance revenue grow organically ahead assumption revenue fall degree anticipate relate generate approximately million revenue relate product service close double million project slightly million generate second quarter approximately million relate revenue come core product remainder come relate service also highlight others noticeable uptick demand test extraction latter half quarter contribution recently award test contract department health human service mount assume guidance reduce capacity make available state offer begin quarter bring revenue contribution compare first half year however average daily volume increase significantly quarter progress number late surpass test extremely proud able accomplish last year scratch immediately appropriately address workflow challenge come something like short period time middle pandemic successfully meet deliver vary level demand week week month month basis give successful contribution happy report contract state test extend another year relate business segment diagnostics generate million revenue third quarter represent total revenue year year organically business grow organically basis geographically diagnostics business strong around world strong double digit organic growth region relate immunodiagnostics franchise total revenue quarter strong growth product service continue grow robustly organically business fantastic continue invest heavily pace million revenue year mention close acquisition early excite commercial synergy provide exist franchise apply genomics business also fall within broader diagnostics segment continue take share improve brand recognition relate sale business fall equipment relate capacity build continue strong demand reagent relate variant detection high throughput real time workstation explorer continue strong uptick revenue core large molecule activity continue bounce back initially hamper pandemic fund continue remain strong think pandemic impact business believe apply genomics business particular permanently benefit longer term customer much experience high quality instrument sale force even better connect opinion leader space reproductive health business continue face pressure globally decline birth rate particularly able grow business double digit overall combination menu geographic expansion product introduction growth within business modest benefit easier year comp particularly turn discovery analytical solution segment business generate million revenue quarter represent total revenue year year organically business grow lead continue strength life science business double digit growth pharma customer single digit growth academic government market discovery business please close acquisition quarter excite contribution growth large molecule year come sale industrial apply market grow double digit drive strong growth mass spec food single digit look company overall geographic basis double digit growth region greater organic growth lead total company organic growth come basis point guidance operationally extremely please performance light various macro pressure adjust operate margin remain strong drive volume leverage favorable productivity program slightly offset continue investment talent culture research development improve commerce network security infrastructure digital capability strengthen customer relationship expect help drive result year come overall adjust earn share versus year guidance relate balance sheet move piece quarter close finance close finish quarter billion debt approximately million cash free cash flow extremely strong quarter year generate million adjust free cash flow quarter equate conversion income bring adjust free cash flow year first nine month billion conversion rate give strong cash flow better expect earn leverage quarter stand time debt trail month basis billion debt fund acquisition little counterintuitive expect leverage increase next quarter even begin aggressively delever expect earn relate tailwind revenue come relate guidance expect adjust revenue approximately billion assume organic growth million relate revenue contribution neutral impact foreign exchange bottom line expect adjust earn share assume approximately million interest expense rate million million dilute share outstanding give strong performance year date confidence fourth quarter outlook happy report raise full year revenue earn guidance third consecutive quarter year expect billion revenue least organic revenue growth full year bring total adjust revenue billion include contribution tailwind foreign exchange bring adjust earn share guidance year nearly share equate year year growth guidance detail second last page today presentation relate expect total year sale year approximately million would include fourth quarter adjust revenue guidance approximately million contribution faster expect close deal even confident previously announce accretion greater respectively modest dilutive impact fourth quarter result earlier close importantly integration activity commence sooner anticipate mention excite upcoming companywide innovation summit week headquarter additionally able close finance rate slightly deal model current interest rate level overall fantastic outcome close encourage continue perform high level organic inorganic investment dividend look forward transformation business perkinelmer underway excite strong finish year position head year ahead financially also people culture importantly customer like turn operator begin